Este estudio de fase I/II en tumores sólidos se convierte en el primer ensayo de la industria farmacéutica autorizado en nuestro país bajo las nuevas guías fast track, con un proceso regulatorio q...
Read more
The funds raised will allow PlusVitech to immediately launch a Phase 1/2 clinical trial involving 42 patients with advanced lung cancer, aimed at validating the efficacy of its PVT-01 treatment. In pa...
Read more
Key combination for the treatment of Small Cell Lung Cancer
Read more
El engasertib, una molécula oral diseñada exclusivamente para la enfermedad, reduce de forma significativa las hemorragias nasales graves, que pueden durar horas y obligar a transfusiones repetidas....
Read more
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause transthyretin amyloidosis (ATTR), a group of fatal progress...
Read more
Atlas Molecular Pharma (Atlas), a biotechnology company and spin-off of CIC bioGUNE, has closed a €3 million investment round aimed at driving the clinical development of ATL-001, its oral clinical-...
Read more
A new class of light-activatable molecules has been developed, enabling precise modulation of the vitamin D receptor
Read more
Una de las solicitudes aprobadas ha sido el proyecto FORMULAM561 , de Laminar Pharma y en colaboración con la Fundación Teófilo Hernando y la Fundación para la Investigación Biomédica del Hospit...
Read more
Oriva Therapeutics, a women’s health company developing first-in-class and best-in-class approaches to treat chronic, prevalent conditions affecting women, announced today its incorporation, as well...
Read more
The three winning projects range from new platforms for discovering antiamyloid drugs, to advanced metabolic analysis technologies, to optical tools for studying the brains of animals moving naturally...
Read more
El proyecto obtiene 150.000 euros del Consejo Europeo de Investigación para impulsar un posible tratamiento capaz de restaurar la función de las células del páncreas encargadas de producir insulin...
Read more
Oryzon Genomics has received a “Decision to grant” communication from the Japanese Patent Office for its patent application JP2023-136283, titled “Methods of treating behavior alterations”, re...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
